Today in science: a new Alzheimer's drug that actually repairs brain DNA, a radio beacon near a black hole that has astronomers scratching their heads, a sugar-coated therapy that boosted brain cancer survival by 50% in mice, and the possibility that dark matter has been hiding in a dimension we've never seen. Let's get into it.

A new Alzheimer's drug is turning heads in neuroscience for doing something researchers have long hoped for but rarely achieved: it repairs DNA damage inside brain cells while simultaneously reducing inflammation. The dual-action approach targets two of the most destructive processes believed to drive Alzheimer's progression.

What makes this particularly significant is that DNA damage in neurons has been increasingly recognized as a key feature of Alzheimer's disease - not just a side effect. By addressing that damage directly, this drug goes after a root cause rather than just managing symptoms.

Brain inflammation, the other target, is also a well-documented accelerant of cognitive decline. A therapy that tackles both simultaneously could represent a meaningful leap forward for the millions of people living with Alzheimer's and the families supporting them.

Astronomers have detected a mysterious radio beacon located near a black hole - and it's behaving in ways that defy current expectations. The signal is drawing significant attention precisely because it doesn't fit neatly into any existing model of what we know about black hole environments.

Black holes are already among the most extreme environments in the universe, where gravity distorts space and time. A radio source pulsing in their vicinity could be tied to jets of material, interactions with surrounding gas, or something entirely new. The fact that it "defies expectations" suggests it may not match known categories like pulsars or magnetars.

Unexplained cosmic signals like this one are often where the most important discoveries begin. Researchers will now work to characterize the beacon's behavior over time - and what they find could reshape our understanding of the physics closest to these cosmic giants.

Dark matter makes up the majority of matter in the universe, yet we've never directly detected it. A bold new hypothesis now suggests it might be hiding somewhere we've never looked: a hidden fifth dimension beyond the three spatial dimensions and time we experience every day.

The idea builds on theoretical frameworks in physics that allow for extra dimensions too small or too "curled up" to be observed directly. If dark matter particles exist in such a dimension, they would interact with our world only through gravity - which would explain why they've eluded every detector built so far.

This kind of theoretical leap is exactly how physics moves forward. While it remains a hypothesis, it opens new experimental directions and reminds us that the universe may be far stranger - and more layered - than our current picture suggests.

Glioblastoma is one of the most devastating and treatment-resistant cancers known to medicine. Now, researchers have developed a sugar-coated therapy that boosted survival against this deadly brain cancer by 50% in mouse models - a result that's generating real excitement in the oncology world.

The "sugar-coating" approach is likely a delivery mechanism - using sugar molecules to help the therapeutic agent slip past the brain's formidable defenses, including the blood-brain barrier, which notoriously blocks most drugs from reaching tumors. Getting treatment to the right place has long been the central challenge in brain cancer therapy.

A 50% improvement in survival in preclinical models is a striking number. The path from mouse studies to human trials is long, but results this strong in animal models are exactly what moves a therapy into the next phase of testing.

GLP-1 drugs like semaglutide have become cultural phenomena, celebrated for producing dramatic weight loss. But new research is shining a light on a significant tradeoff that often goes unmentioned in the headlines: these drugs may not distinguish well between fat and muscle when the weight comes off.

Muscle loss during weight reduction is a well-known concern in medicine, but the scale of it with GLP-1 agonists is prompting researchers to ask harder questions. Muscle mass is critical not just for physical strength but for metabolism, bone density, and long-term health - losing too much of it can create its own set of problems.

This doesn't mean these drugs aren't valuable - for many patients, the benefits are real and life-changing. But it does mean the conversation around them needs to be more complete. Researchers are now exploring whether resistance training, dietary protein, or combination therapies can help preserve muscle during treatment.

In a remarkable feat of engineering, scientists have built a camera capable of tracking invisible particles in three dimensions. Particles that leave no visible trace have historically been among the hardest to study - this new tool changes that by making their movements recordable and analyzable in 3D space.

The implications reach across multiple fields. In physics, tracking subatomic particles in three dimensions opens new windows into fundamental interactions. In medicine and environmental science, the ability to follow invisible particles through complex environments could transform how we understand everything from drug delivery to air pollution dynamics.

Tools like this are often quiet revolutions - they don't make a single discovery, they make many future discoveries possible. By giving researchers a new way to see what was previously unseeable, this camera could become a foundational instrument in laboratories for years to come.

A new fossil study is challenging the classic, linear story of human evolution - the familiar image of a single lineage marching steadily toward modern humanity. The findings suggest our origins were far messier, more branching, and more complex than the textbook version.

Paleoanthropology has been moving in this direction for years, with each new fossil discovery adding complexity to the family tree. But studies that directly challenge the "classic story" signal that even our established frameworks may need significant revision. Evolution, it turns out, rarely moves in a straight line.

For anyone who has ever wondered where we truly come from, this research is a reminder that the answer is still being written - and that the real story of humanity is far more interesting than any simple narrative could capture.

From the depths of our own DNA to the edge of black holes, today's science reminds us that the most profound questions are still wide open - and the answers, when they come, always seem to reveal something even stranger underneath. See you next time.